•HRES 1099 EH 
Sec. 3253. Authority to make grants. 
Sec. 3254. Application. 
Sec. 3255. Use of grant funds. 
Sec. 3256. Eligibility for grant. 
Sec. 3257. Duration of grants. 
Sec. 3258. Accountability and oversight. 
Sec. 3259. Duration of program. 
Sec. 3260. Authorization of appropriations. 
CHAPTER 7—USING DATA TO PREVENT OPIOID DIVERSION 
Sec. 3271. Short title. 
Sec. 3272. Purpose. 
Sec. 3273. Amendments. 
Sec. 3274. Report. 
CHAPTER 8—OPIOID QUOTA REFORM 
Sec. 3281. Short title. 
Sec. 3282. Strengthening considerations for DEA opioid quotas. 
CHAPTER 9—PREVENTING DRUG DIVERSION 
Sec. 3291. Short title. 
Sec. 3292. Improvements to prevent drug diversion. 
TITLE IV—OFFSETS 
Sec. 4001. Promoting value in Medicaid managed care. 
Sec. 4002. Requiring reporting by group health plans of prescription drug cov-
erage information for purposes of identifying primary payer sit-
uations under the Medicare program. 
Sec. 4003. Additional religious exemption from health coverage responsibility 
requirement. 
Sec. 4004. Modernizing the reporting of biological and biosimilar products. 
TITLE V—OTHER MEDICAID PROVISIONS 
Subtitle A—Mandatory Reporting With Respect to Adult Behavioral Health 
Measures 
Sec. 5001. Mandatory reporting with respect to adult behavioral health meas-
ures. 
Subtitle B—Medicaid IMD Additional Info 
Sec. 5011. Short title. 
Sec. 5012. MACPAC exploratory study and report on institutions for mental 
diseases requirements and practices under Medicaid. 
Subtitle C—CHIP Mental Health and Substance Use Disorder Parity 
Sec. 5021. Short title. 
Sec. 5022. Ensuring access to mental health and substance use disorder serv-
ices for children and pregnant women under the Children’s 
Health Insurance Program. 
Subtitle D—Medicaid Reentry
•HRES 1099 EH 
Sec. 5031. Short title. 
Sec. 5032. Promoting State innovations to ease transitions integration to the 
community for certain individuals. 
Subtitle E—Medicaid Partnership 
Sec. 5041. Short title. 
Sec. 5042. Medicaid providers are required to note experiences in record sys-
tems to help in-need patients. 
Subtitle F—IMD CARE Act 
Sec. 5051. Short title. 
Sec. 5052. State option to provide Medicaid coverage for certain individuals 
with substance use disorders who are patients in certain insti-
tutions for mental diseases. 
Subtitle G—Medicaid Improvement Fund 
Sec. 5061. Medicaid Improvement Fund. 
TITLE VI—OTHER MEDICARE PROVISIONS 
Subtitle A—Testing of Incentive Payments for Behavioral Health Providers 
for Adoption and Use of Certified Electronic Health Record Technology 
Sec. 6001. Testing of incentive payments for behavioral health providers for 
adoption and use of certified electronic health record tech-
nology. 
Subtitle B—Abuse Deterrent Access 
Sec. 6011. Short title. 
Sec. 6012. Study on abuse-deterrent opioid formulations access barriers under 
Medicare. 
Subtitle C—Medicare Opioid Safety Education 
Sec. 6021. Medicare opioid safety education. 
Subtitle D—Opioid Addiction Action Plan 
Sec. 6031. Short title. 
Sec. 6032. Action plan on recommendations for changes under Medicare and 
Medicaid to prevent opioids addictions and enhance access to 
medication-assisted treatment. 
Subtitle E—Advancing High Quality Treatment for Opioid Use Disorders in 
Medicare 
Sec. 6041. Short title. 
Sec. 6042. Opioid use disorder treatment demonstration program. 
Subtitle F—Responsible Education Achieves Care and Healthy Outcomes for 
Users’ Treatment 
Sec. 6051. Short title. 
Sec. 6052. Grants to provide technical assistance to outlier prescribers of 
opioids.
•HRES 1099 EH 
Subtitle G—Preventing Addiction for Susceptible Seniors 
Sec. 6061. Short title. 
Sec. 6062. Electronic prior authorization for covered part D drugs. 
Sec. 6063. Program integrity transparency measures under Medicare parts C 
and D. 
Sec. 6064. Expanding eligibility for medication therapy management programs 
under part D. 
Sec. 6065. Commit to opioid medical prescriber accountability and safety for 
seniors. 
Sec. 6066. No additional funds authorized. 
Subtitle H—Expanding Oversight of Opioid Prescribing and Payment 
Sec. 6071. Short title. 
Sec. 6072. Medicare Payment Advisory Commission report on opioid payment, 
adverse incentives, and data under the Medicare program. 
Sec. 6073. No additional funds authorized. 
Subtitle I—Dr. Todd Graham Pain Management, Treatment, and Recovery 
Sec. 6081. Short title. 
Sec. 6082. Review and adjustment of payments under the Medicare outpatient 
prospective payment system to avoid financial incentives to use 
opioids instead of non-opioid alternative treatments. 
Sec. 6083. Expanding access under the Medicare program to addiction treat-
ment in Federally qualified health centers and rural health 
clinics. 
Sec. 6084. Studying the availability of supplemental benefits designed to treat 
or prevent substance use disorders under Medicare Advantage 
plans. 
Sec. 6085. Clinical psychologist services models under the Center for Medicare 
and Medicaid Innovation; GAO study and report. 
Sec. 6086. Dr. Todd Graham pain management study. 
Subtitle J—Combating Opioid Abuse for Care in Hospitals 
Sec. 6091. Short title. 
Sec. 6092. Developing guidance on pain management and opioid use disorder 
prevention for hospitals receiving payment under part A of the 
Medicare program. 
Sec. 6093. Requiring the review of quality measures relating to opioids and 
opioid use disorder treatments furnished under the medicare 
program and other federal health care programs. 
Sec. 6094. Technical expert panel on reducing surgical setting opioid use; Data 
collection on perioperative opioid use. 
Sec. 6095. Requiring the posting and periodic update of opioid prescribing 
guidance for Medicare beneficiaries. 
Subtitle K—Providing Reliable Options for Patients and Educational 
Resources 
Sec. 6101. Short title. 
Sec. 6102. Requiring Medicare Advantage plans and part D prescription drug 
plans to include information on risks associated with opioids 
and coverage of nonpharmacological therapies and nonopioid 
medications or devices used to treat pain.
•HRES 1099 EH 
Sec. 6103. Requiring Medicare Advantage plans and prescription drug plans to 
provide information on the safe disposal of prescription drugs. 
Sec. 6104. Revising measures used under the Hospital Consumer Assessment 
of Healthcare Providers and Systems survey relating to pain 
management. 
Subtitle L—Fighting the Opioid Epidemic With Sunshine 
Sec. 6111. Fighting the opioid epidemic with sunshine. 
TITLE VII—PUBLIC HEALTH PROVISIONS 
Subtitle A—Awareness and Training 
Sec. 7001. Report on effects on public health of synthetic drug use. 
Sec. 7002. First responder training. 
Subtitle B—Pilot Program for Public Health Laboratories To Detect 
Fentanyl and Other Synthetic Opioids 
Sec. 7011. Pilot program for public health laboratories to detect fentanyl and 
other synthetic opioids. 
Subtitle C—Indexing Narcotics, Fentanyl, and Opioids 
Sec. 7021. Establishment of substance use disorder information dashboard. 
Sec. 7022. Interdepartmental Substance Use Disorders Coordinating Com-
mittee. 
Sec. 7023. National milestones to measure success in curtailing the opioid cri-
sis. 
Sec. 7024. Study on prescribing limits. 
Subtitle D—Ensuring Access to Quality Sober Living 
Sec. 7031. National recovery housing best practices. 
Subtitle E—Advancing Cutting Edge Research 
Sec. 7041. Unique research initiatives. 
Sec. 7042. Pain research. 
Subtitle F—Jessie’s Law 
Sec. 7051. Inclusion of opioid addiction history in patient records. 
Sec. 7052. Communication with families during emergencies. 
Sec. 7053. Development and dissemination of model training programs for sub-
stance use disorder patient records. 
Subtitle G—Protecting Pregnant Women and Infants 
Sec. 7061. Report on addressing maternal and infant health in the opioid crisis. 
Sec. 7062. Protecting moms and infants. 
Sec. 7063. Early interventions for pregnant women and infants. 
Sec. 7064. Prenatal and postnatal health. 
Sec. 7065. Plans of safe care. 
Subtitle H—Substance Use Disorder Treatment Workforce 
Sec. 7071. Loan repayment program for substance use disorder treatment 
workforce.
•HRES 1099 EH 
Sec. 7072. Clarification regarding service in schools and other community-based 
settings. 
Sec. 7073. Programs for health care workforce. 
Subtitle I—Preventing Overdoses While in Emergency Rooms 
Sec. 7081. Program to support coordination and continuation of care for drug 
overdose patients. 
Subtitle J—Alternatives to Opioids in the Emergency Department 
Sec. 7091. Emergency department alternatives to opioids demonstration pro-
gram. 
Subtitle K—Treatment, Education, and Community Help To Combat 
Addiction 
Sec. 7101. Establishment of regional centers of excellence in substance use dis-
order education. 
Sec. 7102. Youth prevention and recovery. 
Subtitle L—Information From National Mental Health and Substance Use 
Policy Laboratory 
Sec. 7111. Information from National Mental Health and Substance Use Policy 
Laboratory. 
Subtitle M—Comprehensive Opioid Recovery Centers 
Sec. 7121. Comprehensive opioid recovery centers. 
Subtitle N—Trauma-Informed Care 
Sec. 7131. CDC surveillance and data collection for child, youth, and adult 
trauma. 
Sec. 7132. Task force to develop best practices for trauma-informed identifica-
tion, referral, and support. 
Sec. 7133. National Child Traumatic Stress Initiative. 
Sec. 7134. Grants to improve trauma support services and mental health care 
for children and youth in educational settings. 
Sec. 7135. Recognizing early childhood trauma related to substance abuse. 
Subtitle O—Eliminating Opioid Related Infectious Diseases 
Sec. 7141. Reauthorization and expansion of program of surveillance and edu-
cation regarding infections associated with illicit drug use and 
other risk factors. 
Subtitle P—Peer Support Communities of Recovery 
Sec. 7151. Building communities of recovery. 
Sec. 7152. Peer support technical assistance center. 
Subtitle Q—Creating Opportunities That Necessitate New and Enhanced 
Connections That Improve Opioid Navigation Strategies 
Sec. 7161. Preventing overdoses of controlled substances. 
Sec. 7162. Prescription drug monitoring program.
•HRES 1099 EH 
Subtitle R—Review of Substance Use Disorder Treatment Providers Receiving 
Federal Funding 
Sec. 7171. Review of substance use disorder treatment providers receiving Fed-
eral funding. 
Subtitle S—Other Health Provisions 
Sec. 7181. State response to the opioid abuse crisis. 
Sec. 7182. Report on investigations regarding parity in mental health and sub-
stance use disorder benefits. 
Sec. 7183. CAREER Act. 
TITLE VIII—MISCELLANEOUS 
Subtitle A—Synthetics Trafficking and Overdose Prevention 
Sec. 8001. Short title. 
Sec. 8002. Customs fees. 
Sec. 8003. Mandatory advance electronic information for postal shipments. 
Sec. 8004. International postal agreements. 
Sec. 8005. Cost recoupment. 
Sec. 8006. Development of technology to detect illicit narcotics. 
Sec. 8007. Civil penalties for postal shipments. 
Sec. 8008. Report on violations of arrival, reporting, entry, and clearance re-
quirements and falsity or lack of manifest. 
Sec. 8009. Effective date; regulations. 
Subtitle B—Opioid Addiction Recovery Fraud Prevention 
Sec. 8021. Short title. 
Sec. 8022. Definitions. 
Sec. 8023. Unfair or deceptive acts or practices with respect to substance use 
disorder treatment service and products. 
Subtitle C—Addressing Economic and Workforce Impacts of the Opioid Crisis 
Sec. 8041. Addressing economic and workforce impacts of the opioid crisis. 
Subtitle D—Peer Support Counseling Program for Women Veterans 
Sec. 8051. Peer support counseling program for women veterans. 
Subtitle E—Treating Barriers to Prosperity 
Sec. 8061. Short title. 
Sec. 8062. Drug abuse mitigation initiative. 
Subtitle F—Pilot Program to Help Individuals in Recovery From a Substance 
Use Disorder Become Stably Housed 
Sec. 8071. Pilot program to help individuals in recovery from a substance use 
disorder become stably housed. 
Subtitle G—Human Services 
Sec. 8081. Supporting family-focused residential treatment. 
Sec. 8082. Improving recovery and reunifying families. 
Sec. 8083. Building capacity for family-focused residential treatment.
•HRES 1099 EH 
Subtitle H—Reauthorizing and Extending Grants for Recovery From Opioid 
Use Programs 
Sec. 8091. Short title. 
Sec. 8092. Reauthorization of the comprehensive opioid abuse grant program. 
Subtitle I—Fighting Opioid Abuse in Transportation 
Sec. 8101. Short title. 
Sec. 8102. Alcohol and controlled substance testing of mechanical employees. 
Sec. 8103. Department of Transportation public drug and alcohol testing data-
base. 
Sec. 8104. GAO report on Department of Transportation’s collection and use 
of drug and alcohol testing data. 
Sec. 8105. Transportation Workplace Drug and Alcohol Testing Program; addi-
tion of fentanyl and other substances. 
Sec. 8106. Status reports on hair testing guidelines. 
Sec. 8107. Mandatory Guidelines for Federal Workplace Drug Testing Pro-
grams using Oral Fluid. 
Sec. 8108. Electronic recordkeeping. 
Sec. 8109. Status reports on Commercial Driver’s License Drug and Alcohol 
Clearinghouse. 
Subtitle J—Eliminating Kickbacks in Recovery 
Sec. 8121. Short title. 
Sec. 8122. Criminal penalties. 
Subtitle K—Substance Abuse Prevention 
Sec. 8201. Short title. 
Sec. 8202. Reauthorization of the Office of National Drug Control Policy. 
Sec. 8203. Reauthorization of the Drug-Free Communities Program. 
Sec. 8204. Reauthorization of the National Community Anti-Drug Coalition In-
stitute. 
Sec. 8205. Reauthorization of the High-Intensity Drug Trafficking Area Pro-
gram. 
Sec. 8206. Reauthorization of drug court program. 
Sec. 8207. Drug court training and technical assistance. 
Sec. 8208. Drug overdose response strategy. 
Sec. 8209. Protecting law enforcement officers from accidental exposure. 
Sec. 8210. COPS Anti-Meth Program. 
Sec. 8211. COPS anti-heroin task force program. 
Sec. 8212. Comprehensive Addiction and Recovery Act education and aware-
ness. 
Sec. 8213. Reimbursement of substance use disorder treatment professionals. 
Sec. 8214. Sobriety Treatment and Recovery Teams (START). 
Sec. 8215. Provider education. 
Sec. 8216. Definitions. 
Sec. 8217. Amendments to administration of the Office. 
Sec. 8218. Emerging threats committee, plan, and media campaign. 
Sec. 8219. Drug interdiction. 
Sec. 8220. GAO Audit. 
Sec. 8221. National Drug Control Strategy. 
Sec. 8222. Technical and conforming amendments to the Office of National 
Drug Control Policy Reauthorization Act of 1998.
•HRES 1099 EH 
Subtitle L—Budgetary Effects 
Sec. 8231. Budgetary effect. 
TITLE I—MEDICAID PROVISIONS 
TO ADDRESS THE OPIOID CRISIS 
SEC. 1001. AT-RISK YOUTH MEDICAID PROTECTION. 
(a) IN GENERAL.—Section 1902 of the Social Security 
Act (42 U.S.C. 1396a) is amended— 
(1) in subsection (a)— 
(A) by striking ‘‘and’’ at the end of paragraph 
(82); 
(B) by striking the period at the end of para-
graph (83) and inserting ‘‘; and’’; and 
(C) by inserting after paragraph (83) the fol-
lowing new paragraph: 
‘‘(84) provide that— 
‘‘(A) the State shall not terminate eligibility 
for medical assistance under the State plan for an 
individual who is an eligible juvenile (as defined in 
subsection (nn)(2)) because the juvenile is an in-
mate of a public institution (as defined in sub-
section (nn)(3)), but may suspend coverage during 
the period the juvenile is such an inmate; 
‘‘(B) in the case of an individual who is an eli-
gible juvenile described in paragraph (2)(A) of sub-
section (nn), the State shall, prior to the individ-
ual’s release from such a public institution, conduct
•HRES 1099 EH 
a redetermination of eligibility for such individual 
with respect to such medical assistance (without re-
quiring a new application from the individual) and, 
if the State determines pursuant to such redeter-
mination that the individual continues to meet the 
eligibility requirements for such medical assistance, 
the State shall restore coverage for such medical as-
sistance to such an individual upon the individual’s 
release from such public institution; and 
‘‘(C) in the case of an individual who is an eli-
gible juvenile described in paragraph (2)(B) of sub-
section (nn), the State shall process any application 
for medical assistance submitted by, or on behalf of, 
such individual such that the State makes a deter-
mination of eligibility for such individual with re-
spect to such medical assistance upon release of 
such individual from such public institution.’’; and 
(2) by adding at the end the following new sub-
section: 
‘‘(nn) JUVENILE; ELIGIBLE JUVENILE; PUBLIC INSTI-
TUTION.—For purposes of subsection (a)(84) and this sub-
section: 
‘‘(1) JUVENILE.—The term ‘juvenile’ means an in-
dividual who is— 
‘‘(A) under 21 years of age; or
•HRES 1099 EH 
‘‘(B) described in subsection (a)(10)(A)(i)(IX). 
‘‘(2) ELIGIBLE JUVENILE.—The term ‘eligible juve-
nile’ means a juvenile who is an inmate of a public insti-
tution and who— 
‘‘(A) was determined eligible for medical assist-
ance under the State plan immediately before be-
coming an inmate of such a public institution; or 
‘‘(B) is determined eligible for such medical as-
sistance while an inmate of a public institution. 
‘‘(3) INMATE
OF
A
PUBLIC
INSTITUTION.—The 
term ‘inmate of a public institution’ has the meaning 
given such term for purposes of applying the subdivision 
(A) following paragraph (30) of section 1905(a), taking 
into account the exception in such subdivision for a pa-
tient of a medical institution.’’. 
(b) NO CHANGE IN EXCLUSION FROM MEDICAL ASSIST-
ANCE FOR INMATES OF PUBLIC INSTITUTIONS.—Nothing in 
this section shall be construed as changing the exclusion from 
medical assistance under the subdivision (A) following para-
graph (30) of section 1905(a) of the Social Security Act (42 
U.S.C. 1396d(a)), as redesignated by section 1006(b)(2)(B) 
of this Act, including any applicable restrictions on a State 
submitting claims for Federal financial participation under 
title XIX of such Act for such assistance.
•HRES 1099 EH 
(c) NO CHANGE IN CONTINUITY OF ELIGIBILITY BE-
FORE ADJUDICATION OR SENTENCING.—Nothing in this sec-
tion shall be construed to mandate, encourage, or suggest 
that a State suspend or terminate coverage for individuals be-
fore they have been adjudicated or sentenced. 
(d) EFFECTIVE DATE.— 
(1) IN GENERAL.—Except as provided in paragraph 
(2), the amendments made by subsection (a) shall apply 
to eligibility of juveniles who become inmates of public 
institutions on or after the date that is 1 year after the 
date of the enactment of this Act. 
(2) RULE FOR CHANGES REQUIRING STATE LEGIS-
LATION.—In the case of a State plan for medical assist-
ance under title XIX of the Social Security Act which 
the Secretary of Health and Human Services determines 
requires State legislation (other than legislation appro-
priating funds) in order for the plan to meet the addi-
tional requirements imposed by the amendments made 
by subsection (a), the State plan shall not be regarded 
as failing to comply with the requirements of such title 
solely on the basis of its failure to meet these additional 
requirements before the first day of the first calendar 
quarter beginning after the close of the first regular ses-
sion of the State legislature that begins after the date 
of the enactment of this Act. For purposes of the pre-
•HRES 1099 EH 
vious sentence, in the case of a State that has a 2-year 
legislative session, each year of such session shall be 
deemed to be a separate regular session of the State leg-
islature. 
SEC. 1002. HEALTH INSURANCE FOR FORMER FOSTER YOUTH. 
(a) COVERAGE CONTINUITY FOR FORMER FOSTER CARE 
CHILDREN UP TO AGE 26.— 
(1) IN GENERAL.—Section 1902(a)(10)(A)(i)(IX) of 
the 
Social 
Security 
Act 
(42 
U.S.C. 
1396a(a)(10)(A)(i)(IX)) is amended— 
(A) in item (bb), by striking ‘‘are not described 
in or enrolled under’’ and inserting ‘‘are not de-
scribed in and are not enrolled under’’; 
(B) in item (cc), by striking ‘‘responsibility of 
the State’’ and inserting ‘‘responsibility of a State’’; 
and 
(C) in item (dd), by striking ‘‘the State plan 
under this title or under a waiver of the’’ and in-
serting ‘‘a State plan under this title or under a 
waiver of such a’’. 
(2) EFFECTIVE DATE.—The amendments made by 
this subsection shall take effect with respect to foster 
youth who attain 18 years of age on or after January 
1, 2023.
•HRES 1099 EH 
(b) GUIDANCE.—Not later than 1 year after the date of 
the enactment of this Act, the Secretary of Health and 
Human Services shall issue guidance to States, with respect 
to the State Medicaid programs of such States— 
(1) on best practices for— 
(A) removing barriers and ensuring stream-
lined, timely access to Medicaid coverage for former 
foster youth up to age 26; and 
(B) conducting outreach and raising awareness 
among such youth regarding Medicaid coverage op-
tions for such youth; and 
(2) which shall include examples of States that have 
successfully extended Medicaid coverage to former foster 
youth up to age 26. 
SEC. 1003. DEMONSTRATION PROJECT TO INCREASE SUB-
STANCE USE PROVIDER CAPACITY UNDER THE 
MEDICAID PROGRAM. 
Section 1903 of the Social Security Act (42 U.S.C. 
1396b) is amended by adding at the end the following new 
subsection: 
‘‘(aa) DEMONSTRATION PROJECT TO INCREASE SUB-
STANCE USE PROVIDER CAPACITY.— 
‘‘(1) IN GENERAL.—Not later than the date that is 
180 days after the date of the enactment of this sub-
section, the Secretary shall, in consultation, as appro-
•HRES 1099 EH 
priate, with the Director of the Agency for Healthcare 
Research and Quality and the Assistant Secretary for 
Mental Health and Substance Use, conduct a 54-month 
demonstration project for the purpose described in para-
graph (2) under which the Secretary shall— 
‘‘(A) for the first 18-month period of such 
project, award planning grants described in para-
graph (3); and 
‘‘(B) for the remaining 36-month period of 
such project, provide to each State selected under 
paragraph (4) payments in accordance with para-
graph (5). 
‘‘(2) PURPOSE.—The purpose described in this 
paragraph is for each State selected under paragraph (4) 
to increase the treatment capacity of providers partici-
pating under the State plan (or a waiver of such plan) 
to provide substance use disorder treatment or recovery 
services under such plan (or waiver) through the fol-
lowing activities: 
‘‘(A) For the purpose described in paragraph 
(3)(C)(i), activities that support an ongoing assess-
ment of the behavioral health treatment needs of 
the State, taking into account the matters described 
in subclauses (I) through (IV) of such paragraph.
•HRES 1099 EH 
‘‘(B) Activities that, taking into account the 
results of the assessment described in subparagraph 
(A), support the recruitment, training, and provi-
sion of technical assistance for providers partici-
pating under the State plan (or a waiver of such 
plan) that offer substance use disorder treatment or 
recovery services. 
‘‘(C) Improved reimbursement for and expan-
sion of, through the provision of education, training, 
and technical assistance, the number or treatment 
capacity of providers participating under the State 
plan (or waiver) that— 
‘‘(i) are authorized to dispense drugs ap-
proved by the Food and Drug Administration 
for individuals with a substance use disorder 
who need withdrawal management or mainte-
nance treatment for such disorder; 
‘‘(ii) have in effect a registration or waiver 
under section 303(g) of the Controlled Sub-
stances Act for purposes of dispensing narcotic 
drugs to individuals for maintenance treatment 
or detoxification treatment and are in compli-
ance with any regulation promulgated by the 
Assistant Secretary for Mental Health and
•HRES 1099 EH 
Substance Use for purposes of carrying out the 
requirements of such section 303(g); and 
‘‘(iii) are qualified under applicable State 
law to provide substance use disorder treat-
ment or recovery services. 
‘‘(D) Improved reimbursement for and expan-
sion of, through the provision of education, training, 
and technical assistance, the number or treatment 
capacity of providers participating under the State 
plan (or waiver) that have the qualifications to ad-
dress the treatment or recovery needs of— 
‘‘(i) individuals enrolled under the State 
plan (or a waiver of such plan) who have neo-
natal abstinence syndrome, in accordance with 
guidelines issued by the American Academy of 
Pediatrics and American College of Obstetri-
cians and Gynecologists relating to maternal 
care and infant care with respect to neonatal 
abstinence syndrome; 
‘‘(ii) pregnant women, postpartum women, 
and infants, particularly the concurrent treat-
ment, as appropriate, and comprehensive case 
management of pregnant women, postpartum 
women and infants, enrolled under the State 
plan (or a waiver of such plan);
•HRES 1099 EH 
‘‘(iii) adolescents and young adults be-
tween the ages of 12 and 21 enrolled under the 
State plan (or a waiver of such plan); or 
‘‘(iv) American Indian and Alaska Native 
individuals enrolled under the State plan (or a 
waiver of such plan). 
‘‘(3) PLANNING GRANTS.— 
‘‘(A) IN GENERAL.—The Secretary shall, with 
respect to the first 18-month period of the dem-
onstration project conducted under paragraph (1), 
award planning grants to at least 10 States selected 
in accordance with subparagraph (B) for purposes 
of preparing an application described in paragraph 
(4)(C) and carrying out the activities described in 
subparagraph (C). 
‘‘(B) SELECTION.—In selecting States for pur-
poses of this paragraph, the Secretary shall— 
‘‘(i) select States that have a State plan 
(or waiver of the State plan) approved under 
this title; 
‘‘(ii) select States in a manner that en-
sures geographic diversity; and 
‘‘(iii) give preference to States with a 
prevalence of substance use disorders (in par-
ticular opioid use disorders) that is comparable
•HRES 1099 EH 
to or higher than the national average preva-
lence, as measured by aggregate per capita 
drug overdoses, or any other measure that the 
Secretary deems appropriate. 
‘‘(C) ACTIVITIES
DESCRIBED.—Activities de-
scribed in this subparagraph are, with respect to a 
State, each of the following: 
‘‘(i) Activities that support the develop-
ment of an initial assessment of the behavioral 
health treatment needs of the State to deter-
mine the extent to which providers are needed 
(including the types of such providers and geo-
graphic area of need) to improve the network 
of providers that treat substance use disorders 
under the State plan (or waiver), including the 
following: 
‘‘(I) An estimate of the number of in-
dividuals enrolled under the State plan (or 
a waiver of such plan) who have a sub-
stance use disorder. 
‘‘(II) Information on the capacity of 
providers to provide substance use dis-
order treatment or recovery services to in-
dividuals enrolled under the State plan (or 
waiver), including information on pro-
•HRES 1099 EH 
viders who provide such services and their 
participation under the State plan (or 
waiver). 
‘‘(III) Information on the gap in sub-
stance use disorder treatment or recovery 
services under the State plan (or waiver) 
based on the information described in sub-
clauses (I) and (II). 
‘‘(IV) Projections regarding the ex-
tent to which the State participating 
under the demonstration project would in-
crease the number of providers offering 
substance use disorder treatment or recov-
ery services under the State plan (or waiv-
er) during the period of the demonstration 
project. 
‘‘(ii) Activities that, taking into account 
the results of the assessment described in 
clause (i), support the development of State in-
frastructure to, with respect to the provision of 
substance use disorder treatment or recovery 
services under the State plan (or a waiver of 
such plan), recruit prospective providers and 
provide training and technical assistance to 
such providers.
•HRES 1099 EH 
the State plan) and submits annually to the Sec-
retary such information as the Secretary may re-
quire on activities carried out under such program 
for individuals not more than the age of 18 years 
generally and children in foster care specifically. 
‘‘(C) FRAUD AND ABUSE IDENTIFICATION.— 
The State has in place a process (as designed and 
implemented by the State) that identifies potential 
fraud or abuse of controlled substances by individ-
uals enrolled under the State plan (or under a waiv-
er of the State plan), health care providers pre-
scribing drugs to individuals so enrolled, and phar-
macies dispensing drugs to individuals so enrolled. 
‘‘(D) REPORTS.—The State shall include in the 
annual report submitted to the Secretary under sec-
tion 1927(g)(3)(D) information on the limitations, 
requirement, program, and processes applied by the 
State under subparagraphs (A) through (C) in ac-
cordance with such manner and time as specified by 
the Secretary. 
‘‘(E) CLARIFICATION.—Nothing shall prevent a 
State from satisfying the requirement— 
‘‘(i) described in subparagraph (A) by 
having safety edits or a claims review auto-
•HRES 1099 EH 
SEC. 1006. MEDICAID HEALTH HOMES FOR SUBSTANCE-USE- 
DISORDER MEDICAID ENROLLEES. 
(a) EXTENSION OF ENHANCED FMAP FOR CERTAIN 
HEALTH HOMES FOR INDIVIDUALS WITH SUBSTANCE USE 
DISORDERS.—Section 1945(c) of the Social Security Act (42 
U.S.C. 1396w–4(c)) is amended— 
(1) in paragraph (1), by inserting ‘‘subject to para-
graph (4),’’ after ‘‘except that,’’; and 
(2) by adding at the end the following new para-
graph: 
‘‘(4) SPECIAL RULE RELATING TO SUBSTANCE USE 
DISORDER HEALTH HOMES.— 
‘‘(A) IN
GENERAL.—In the case of a State 
with an SUD-focused State plan amendment ap-
proved by the Secretary on or after October 1, 
2018, the Secretary may, at the request of the 
State, extend the application of the Federal medical 
assistance percentage described in paragraph (1) to 
payments for the provision of health home services 
to SUD-eligible individuals under such State plan 
amendment, in addition to the first 8 fiscal year 
quarters the State plan amendment is in effect, for 
the subsequent 2 fiscal year quarters that the State 
plan amendment is in effect. Nothing in this section 
shall be construed as prohibiting a State with a 
State plan amendment that is approved under this